ID   C17 [Human nasopharyngeal carcinoma]
AC   CVCL_VT47
DR   Cell_Model_Passport; SIDM01989
DR   Wikidata; Q93439148
RX   PubMed=29769697;
CC   Characteristics: Established from a xenograft maintained in athymic nude mice.
CC   Doubling time: ~4.5 days (PubMed=29769697).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): PubMed=29769697
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 20
ST   D21S11: 30
ST   D3S1358: 15
ST   D5S818: 11,14
ST   D7S820: 11
ST   D8S1179: 11,14,15
ST   FGA: 23
ST   Penta D: 12
ST   Penta E: 15,22
ST   TH01: 6
ST   TPOX: 9
ST   vWA: 14,15
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
RX   PubMed=29769697; DOI=10.1038/s41374-018-0034-7;
RA   Yip Y.-L., Lin W.-T., Deng W., Jia L., Lo K.-W., Busson P., Verillaud B.,
RA   Liu X.-F., Tsang C.-M., Lung M.L., Tsao S.-W.;
RT   "Establishment of a nasopharyngeal carcinoma cell line capable of
RT   undergoing lytic Epstein-Barr virus reactivation.";
RL   Lab. Invest. 98:1093-1104(2018).
//